It is a pharma private limited company based in Newdelhi, Delhi, India, established in 2021.
2021 | Newdelhi, Delhi, India | ActiveFenway Pharmaceuticals Private Limited, a active private limited company, was established on 09 June 2021 in Newdelhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239DL2021PTC382105. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.40 Cr and a paid-up capital of ₹7.85 M.
Employing 36 professional, Its leadership includes Akshay Navaladi (Director), Ramesh Navaladi (Director). It holds ₹5.00 Cr open charges and no settled loans. Its latest AGM occurred on 31 December 2022, with the balance sheet filed on 31 March 2022. It is based at 313 Sfs Hauz Khas, Newdelhi, Delhi, 110016.
U24239DL2021PTC382105
382105
09 June 2021
₹3.40 Cr
₹7.85 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Fenway Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Akshay Navaladi | Director | 09 Jun 2021 | Current |
| Ramesh Navaladi | Director | 09 Jun 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Fenway Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2022, Fenway Pharmaceuticals had a public holding of 36.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jan 2022 | Others | ₹5.00 Cr | Open |
Explore comprehensive loan charge details -
Fenway Pharmaceuticals has a workforce of 36 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Fenway Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fenway Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Fenway Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2022 as per latest MCA records. was documented.
The activity Fenway Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi. was completed.
The activity A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100533951 was registered on 27 Jan 2022. was completed.
Akshay Navaladi was appointed as a Director was appointed as a Director on 09 Jun 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.
The activity Ramesh Navaladi was appointed as a Director was appointed as a Director on 09 Jun 2021 & has been associated with this company since 4 years 5 months . was completed.
Fenway Pharmaceuticals Private Limited was registered on 09 Jun 2021 with Roc Delhi & aged 4 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Fenway Pharmaceuticals Private Limited is U24239DL2021PTC382105.
Fenway Pharmaceuticals Private Limited is headquartered at 313 Sfs Hauz Khas, Newdelhi, Delhi, 110016.
Fenway Pharmaceuticals Private Limited was incorporated on 09 June 2021.
The current directors of Fenway Pharmaceuticals Private Limited are
The primary industry of Fenway Pharmaceuticals Private Limited is Trade.
Fenway Pharmaceuticals Private Limited is unlisted.
The authorized capital of Fenway Pharmaceuticals Private Limited is ₹3.40 Cr, and the paid-up capital is ₹7.85 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX